Company Filing History:
2 out of 3 
1 out of 329 
1 out of 3 Years Active: 2013-2018
Title: Cecilia Weigelt: Innovator in Biopharmaceuticals
Introduction
Cecilia Weigelt is a prominent inventor based in Stockholm, Sweden. She has made significant contributions to the field of biopharmaceuticals, particularly in the production and purification of enzymes used in medical treatments. With a total of 4 patents to her name, her work has the potential to impact the treatment of rare genetic disorders.
Latest Patents
Cecilia's latest patents include a process for the production and purification of recombinant lysosomal alpha-mannosidase. This invention relates to a method for purifying recombinant alpha-mannosidase, which is crucial for treating alpha-mannosidosis. Additionally, she has developed a process for the production of recombinant arylsulfatase A, which involves culturing mammalian cells and purifying the enzyme for therapeutic use. These innovations also encompass pharmaceutical compositions that can effectively target and reduce galactosyl sulphatide levels in patients.
Career Highlights
Throughout her career, Cecilia has worked with notable companies such as Shire Pharmaceuticals and Chiesi Farmaceutici. Her expertise in enzyme production and purification has positioned her as a key player in the biopharmaceutical industry.
Collaborations
Cecilia has collaborated with esteemed colleagues, including Jens Fogh and Claes Andersson, to advance her research and innovations in the field.
Conclusion
Cecilia Weigelt's contributions to biopharmaceuticals through her patents and collaborations highlight her role as an influential inventor. Her work continues to pave the way for advancements in the treatment of genetic disorders.